FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula
,
in which m equals 1; n equals 1 or 2; t equals 0 or 1; and A is phenyl, substituted with 2 alkyl groups containing 1 or 2 carbon atoms.
EFFECT: compounds of the disclosed formula can be used as intermediate compounds for producing compounds used to treat various metabolic diseases, such as insulin resistance syndrome, diabetes, hyperlipidaemia, bacony liver, cachexia, obesity, atherosclerosis and arteriosclerosis.
17 tbl, 2 dwg, 53 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TREATMENT OF METABOLIC DISEASES | 2002 |
|
RU2341513C2 |
| COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501554C2 |
| COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501555C2 |
| COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | 2006 |
|
RU2420276C2 |
| TETRAZOLE COMPOUNDS FOR REDUCING CONCENTRATION OF URIC ACID | 2009 |
|
RU2522458C2 |
| AMIDOCARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHOD OF REDUCING GLUCOSE IN BLOOD | 1998 |
|
RU2176999C2 |
| DERIVATIVES OF IMIDAZO[1,2-A]PYRIDINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL PREPARATION BASED ON THEREOF, METHOD OF INHIBITION OF GASTRIC ACID SECRETION, METHOD OF TREATMENT OF GASTROENTERIC INFLAMMATORY DISEASES AND METHOD OF TREATMENT OF STATES WITH HELICOBACTER PYLORI INFECTION | 1998 |
|
RU2193036C2 |
| HETEROCYCLIC COMPOUNDS APPLICABLE AS ALLOSTERIC EFFECTORS IN MUSCARINE RECEPTORS | 1995 |
|
RU2152385C1 |
| PRODRUGS OF THROMBIN INHIBITORS | 1996 |
|
RU2176644C2 |
| THROMBIN INHIBITORS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF TREATMENT, METHOD OF THEIR SYNTHESIS (VERSIONS) AND PROTECTED DERIVATIVE | 1996 |
|
RU2176645C2 |
